BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9079677)

  • 61. SH2 domain specificity and activity modified by a single residue.
    Marengere LE; Songyang Z; Gish GD; Schaller MD; Parsons JT; Stern MJ; Cantley LC; Pawson T
    Nature; 1994 Jun; 369(6480):502-5. PubMed ID: 7515480
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
    Ayrapetov MK; Wang YH; Lin X; Gu X; Parang K; Sun G
    J Biol Chem; 2006 Aug; 281(33):23776-84. PubMed ID: 16790421
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Association of fibroblast growth factor receptor 1 with the adaptor protein Grb14. Characterization of a new receptor binding partner.
    Reilly JF; Mickey G; Maher PA
    J Biol Chem; 2000 Mar; 275(11):7771-8. PubMed ID: 10713090
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. I. Activation of protein kinase C stimulates tyrosine phosphorylation and activation of ErbB2 and ErbB3.
    Emkey R; Kahn CR
    J Biol Chem; 1997 Dec; 272(49):31172-81. PubMed ID: 9388271
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple Grb2-protein complexes in human cancer cells.
    Sastry L; Cao T; King CR
    Int J Cancer; 1997 Jan; 70(2):208-13. PubMed ID: 9009162
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.
    Lung FD; Long YQ; Roller PP; King CR; Varady J; Wu XW; Wang S
    J Pept Res; 2001 Jun; 57(6):447-54. PubMed ID: 11437948
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Uptake of a cell permeable G7-18NATE contruct into cells and binding with the Grb-7-SH2 domain.
    Ambaye ND; Lim RC; Clayton DJ; Gunzburg MJ; Price JT; Pero SC; Krag DN; Wilce MC; Aguilar MI; Perlmutter P; Wilce JA
    Biopolymers; 2011; 96(2):181-8. PubMed ID: 20564009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.
    Stein D; Wu J; Fuqua SA; Roonprapunt C; Yajnik V; D'Eustachio P; Moskow JJ; Buchberg AM; Osborne CK; Margolis B
    EMBO J; 1994 Mar; 13(6):1331-40. PubMed ID: 7907978
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A novel variant of human Grb7 is associated with invasive esophageal carcinoma.
    Tanaka S; Mori M; Akiyoshi T; Tanaka Y; Mafune K; Wands JR; Sugimachi K
    J Clin Invest; 1998 Aug; 102(4):821-7. PubMed ID: 9710451
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions.
    Han DC; Shen TL; Guan JL
    Oncogene; 2001 Oct; 20(44):6315-21. PubMed ID: 11607834
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Csk homologous kinase (CHK) and ErbB-2 interactions are directly coupled with CHK negative growth regulatory function in breast cancer.
    Kim S; Zagozdzon R; Meisler A; Baleja JD; Fu Y; Avraham S; Avraham H
    J Biol Chem; 2002 Sep; 277(39):36465-70. PubMed ID: 12122014
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
    Long YQ; Guo R; Luo JH; Yang D; Roller PP
    Biochem Biophys Res Commun; 2003 Oct; 310(2):334-40. PubMed ID: 14521914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prediction and analysis of SH2 domain-phosphopeptide interactions.
    Zvelebil MJ; Panayotou G; Linacre J; Waterfield MD
    Protein Eng; 1995 Jun; 8(6):527-33. PubMed ID: 8532676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Unexpected involvement of staple leads to redesign of selective bicyclic peptide inhibitor of Grb7.
    Gunzburg MJ; Kulkarni K; Watson GM; Ambaye ND; Del Borgo MP; Brandt R; Pero SC; Perlmutter P; Wilce MC; Wilce JA
    Sci Rep; 2016 Jun; 6():27060. PubMed ID: 27257138
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of a Src kinase SH3 binding site in the C-terminal domain of the human ErbB2 receptor tyrosine kinase.
    Bornet O; Nouailler M; Feracci M; Sebban-Kreuzer C; Byrne D; Halimi H; Morelli X; Badache A; Guerlesquin F
    FEBS Lett; 2014 Jun; 588(12):2031-6. PubMed ID: 24815698
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interaction of the Grb7 adapter protein with Rnd1, a new member of the Rho family.
    Vayssière B; Zalcman G; Mahé Y; Mirey G; Ligensa T; Weidner KM; Chardin P; Camonis J
    FEBS Lett; 2000 Feb; 467(1):91-6. PubMed ID: 10664463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Regulation and functional roles of Grb14.
    Cariou B; Bereziat V; Moncoq K; Kasus-Jacobi A; Perdereau D; Le Marcis V; Burnol AF
    Front Biosci; 2004 May; 9():1626-36. PubMed ID: 14977573
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structural and functional studies of the Ras-associating and pleckstrin-homology domains of Grb10 and Grb14.
    Depetris RS; Wu J; Hubbard SR
    Nat Struct Mol Biol; 2009 Aug; 16(8):833-9. PubMed ID: 19648926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.